Showing results (71-80 of 97) with videos related to
Sort By:
Pageof 10
Science (New York, N.Y.)|March 22, 2003
Role of histone H3 lysine 27 methylation in X inactivationKathrin Plath, Jia Fang, Susanna K Mlynarczyk-Evans, et al.Molecular and Cellular Biology|April 1, 1997
Identification and characterization of interactions between the vertebrate polycomb-group protein BMI1 and human homologs of polyhomeoticM J Gunster, D P Satijn, K M Hamer, et al.British Journal of Cancer|May 14, 2008
Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinomaI B Engelsen, M Mannelqvist, I M Stefansson, et al.Molecular and Cellular Biology|June 20, 1998
Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexesR G Sewalt, J van der Vlag, M J Gunster, et al.Neoplasia (New York, N.Y.)|February 18, 2004
Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 geneFrank M Raaphorst, Chris J L M Meijer, Elly Fieret, et al.Developmental Cell|November 5, 2004
Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivationMariana de Napoles, Jacqueline E Mermoud, Rika Wakao, et al.Molecular and Cellular Biology|October 7, 1997
Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosisD P Satijn, D J Olson, J van der Vlag, et al.Molecular and Cellular Biology|July 1, 1997
RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressorD P Satijn, M J Gunster, J van der Vlag, et al.Nature Genetics|March 4, 2008
PRC1 and Suv39h specify parental asymmetry at constitutive heterochromatin in early mouse embryosMareike Puschendorf, Rémi Terranova, Erwin Boutsma, et al.European Urology|December 1, 2006
Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical featuresGeert J L H van Leenders, Danny Dukers, Daphne Hessels, et al.Pageof 10